Published on March 21, 2007
Exhibit
23.3
CONSENT
OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
To
the
Board of Directors
Novelos
Therapeutics, Inc.
We
consent to the use of our report dated March 19, 2007 in the Registration
Statement No. 333-133043 of Novelos Therapeutics, Inc. on Form SB-2
(Post-Effective Amendment No. 2), relating to the registration of 34,285,449
shares of common stock. We also consent to the use of our name and the reference
to us in the ‘‘Experts’’ section of this registration statement.
/s/
Stowe & Degon
Worcester,
MA
March
21,
2007